Sharepoint Solutions
PRODUCTS
-
SMALL MOLECULE SYNTHESIS, FROM PRECLINICAL TO COMMERCIAL QUANTITIES
With Millipore® CTDMO Services we support small molecule API synthesis projects from milligram to commercial quantities. We are the partner to address the most difficult challenges, whether the target is difficult to handle, synthesize, or source. With a true consultative and partnered approach, our services reduce complexity and minimize program risk in a cost-effective manner.
-
Today’s clinical researchers need precise, timely, and reliable solutions for managing huge amounts of diverse data. TrialKit AI is here to meet this demand.
-
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
-
Get faster process insights and dynamic control of substrate feeding without the loss of bioreactor or fermenter volume.
Keep Your Cells Happy
Fluctuations in glucose levels, associated with infrequent measurements and bolus feeding, may cause metabolic deregulation and undesirable process deviations.
That’s where MAVEN comes in. It has your back, automatically monitoring and controlling glucose and lactate concentrations, helping you realize your PAT strategy.
-
Esco Pharma's Downflow Booth Generation 3 (DFBG3) is a new generation of Esco powder containment booth which provides simplicity with assured quality.
WHITE PAPERS AND CASE STUDIES
-
AMERICAN Plays A Role In Rebuilding Puerto Rico's Infrastructure
AMERICAN is helping rebuild Puerto Rico’s vital water infrastructure after Hurricane Maria, supplying American-made products to strengthen resiliency for 3.5 million residents and millions of annual visitors.
-
What Re-Acquisition In Retinal Imaging Is Really Costing Your Program
High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.
-
NDA Success Strategy: Using Non-US Clinical Data In An NDA Submission
A sponsor acquiring a therapeutic asset from an overseas company sought assistance when including foreign clinical trial dat,a generated outside a U.S. IND, in a New Drug Application (NDA).
-
How Syneos Health Tackles Protocol Complexities
Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase I-IV clinical trials, particularly under a complex adaptive trial protocol.
-
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
Inspecting On The Edge — Understanding Punch Tip Wear
Why is a horizontal optical comparator highly recommended for tablet manufacturers as a measuring tool for punch tip inspection, and what strategies can be used to detect, reduce, and prevent tip wear?
-
Improving Patient Health and Safety: Quality and Analytical Scientist
Explore how an analytical scientist enhanced quality and compliance for a pharmaceutical company by managing complex analytical testing and vendor interactions.
-
A Digital Solution Embeds Quality Into Cellular Therapeutics Production
Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks.
-
Container Selection For A Highly Sensitive Drug Product: A Success Story
Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.
-
Clinical Trial Starts Rose At Slower Pace In 2024
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
NEWS
-
'A More Versatile And Powerful Foundation For Future Photonic Technologies'6/24/2025
The candidate pool for engineered materials that can help enable tomorrow’s cutting-edge optical technologies—such as lasers, detectors and imaging devices—is much deeper than previously believed.
-
Klarna Announces Partnership With OnePay To Exclusively Power Installment Loans At Walmart In The U.S3/17/2025
Klarna, the AI-powered payments and commerce network, today announced that it will be partnering with OnePay, a leading consumer finance app, to exclusively offer installment loans for purchases at Walmart in the United States.
-
WaterEquity's Everspring Fund Expands Household Access To Water And Sanitation Across Emerging Markets3/19/2026
On World Water Day 2025, we announced the creation of the WaterEquity Everspring Fund, which launched four months later.
-
Investigating The 'Glue' That Holds Cells Together3/20/2025
Northwestern Medicine investigators have uncovered new insights into how intercellular “glue” functions to enable interactions between cells, as detailed in a study published in Nature Communications.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research1/15/2026
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.